Cargando…

Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany

By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Geissler, Ferdinand, Hartmann, Felix, Humphreys, Macartan, Klüver, Heike, Giesecke, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750013/
https://www.ncbi.nlm.nih.gov/pubmed/36516143
http://dx.doi.org/10.1371/journal.pone.0278337
_version_ 1784850156201443328
author Geissler, Ferdinand
Hartmann, Felix
Humphreys, Macartan
Klüver, Heike
Giesecke, Johannes
author_facet Geissler, Ferdinand
Hartmann, Felix
Humphreys, Macartan
Klüver, Heike
Giesecke, Johannes
author_sort Geissler, Ferdinand
collection PubMed
description By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vaccination rates. Given that governments need to secure public support for investments in global vaccine sharing, it is important to understand the levels and drivers of public support for international vaccine solidarity. Using a factorial experiment administered to more than 10,000 online survey respondents in Germany in 2021, we demonstrate that the majority of German citizens are against global inequalities in vaccine distribution. Respondents are supportive of substantive funding amounts, on the order of the most generous contributions provided to date, though still below amounts that are likely needed for a successful global campaign. Public preferences appear largely to be driven by intrinsic concern for the welfare of global populations though are in part explained by material considerations—particularly risks of continued health threats from a failure to vaccinate globally. Strategic considerations are of more limited importance in shaping public opinion; in particular we see no evidence for free riding on contributions by other states. Finally, drawing on an additional survey experiment, we show that there is scope to use information campaigns highlighting international health externalities to augment public support for global campaigns.
format Online
Article
Text
id pubmed-9750013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97500132022-12-15 Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany Geissler, Ferdinand Hartmann, Felix Humphreys, Macartan Klüver, Heike Giesecke, Johannes PLoS One Research Article By September 2021 an estimated 32% of the global population was fully vaccinated for COVID-19 but the global distribution of vaccines was extremely unequal, with 72% or more vaccinated in the ten countries with the highest vaccination rates and less than 2% in the ten countries with the lowest vaccination rates. Given that governments need to secure public support for investments in global vaccine sharing, it is important to understand the levels and drivers of public support for international vaccine solidarity. Using a factorial experiment administered to more than 10,000 online survey respondents in Germany in 2021, we demonstrate that the majority of German citizens are against global inequalities in vaccine distribution. Respondents are supportive of substantive funding amounts, on the order of the most generous contributions provided to date, though still below amounts that are likely needed for a successful global campaign. Public preferences appear largely to be driven by intrinsic concern for the welfare of global populations though are in part explained by material considerations—particularly risks of continued health threats from a failure to vaccinate globally. Strategic considerations are of more limited importance in shaping public opinion; in particular we see no evidence for free riding on contributions by other states. Finally, drawing on an additional survey experiment, we show that there is scope to use information campaigns highlighting international health externalities to augment public support for global campaigns. Public Library of Science 2022-12-14 /pmc/articles/PMC9750013/ /pubmed/36516143 http://dx.doi.org/10.1371/journal.pone.0278337 Text en © 2022 Geissler et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Geissler, Ferdinand
Hartmann, Felix
Humphreys, Macartan
Klüver, Heike
Giesecke, Johannes
Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title_full Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title_fullStr Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title_full_unstemmed Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title_short Public support for global vaccine sharing in the COVID-19 pandemic: Evidence from Germany
title_sort public support for global vaccine sharing in the covid-19 pandemic: evidence from germany
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750013/
https://www.ncbi.nlm.nih.gov/pubmed/36516143
http://dx.doi.org/10.1371/journal.pone.0278337
work_keys_str_mv AT geisslerferdinand publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany
AT hartmannfelix publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany
AT humphreysmacartan publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany
AT kluverheike publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany
AT gieseckejohannes publicsupportforglobalvaccinesharinginthecovid19pandemicevidencefromgermany